Soluble human Suppression of Tumorigenicity 2 is associated with endoscopic activity in patients with moderate-to-severe ulcerative colitis treated with golimumab

BACKGROUND: Suppressor of Tumorigenicity 2 (ST2) is an IL33 receptor detected in the mucosa and serum of ulcerative colitis (UC) patients. We evaluated soluble ST2 (sST2) as a surrogate biomarker of disease outcome and therapeutic response, in moderate-to-severe UC patients treated with golimumab. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Magro, Fernando, Lopes, Susana, Silva, Marco, Coelho, Rosa, Portela, Francisco, Branquinho, Diogo, Correia, Luís, Fernandes, Samuel, Cravo, Marília, Caldeira, Paulo, Tavares de Sousa, Helena, Patita, Marta, Lago, Paula, Ramos, Jaime, Afonso, Joana, Redondo, Isabel, Machado, Patrícia, Philip, George, Lopes, Joanne, Carneiro, Fátima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719471/
https://www.ncbi.nlm.nih.gov/pubmed/31516554
http://dx.doi.org/10.1177/1756284819869141

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719471/
https://www.ncbi.nlm.nih.gov/pubmed/31516554
http://dx.doi.org/10.1177/1756284819869141

Ejemplares similares